GlassScriptPhysician profile
Renae Shibata
NPI 1275065518
$1,162.85
in general payments reported to CMS, 2019-2025
7 companies · $20.04 in 2025
The $20.04 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $51.13 · 2023: $1,029 · 2024: $62.70 · 2025: $20.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,000 · Food and Beverage: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,000.00 |
| Food and Beverage | $111.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,028.98 | 2023 | Davinci Xi, Da Vinci Surgical System |
| Medtronic, INC. | $51.13 | 2021 | |
| Sumitomo Pharma America, INC. | $20.04 | 2025 | Myfembree |
| Daiichi Sankyo INC. | $17.10 | 2024 | Injectafer |
| Gynesonics, INC. | $15.70 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Coopersurgical, INC. | $15.09 | 2024 | Paragard T 380a |
| Exact Sciences Corporation | $14.81 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Renae Shibata listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.